Market Place
Sourcing Support
Amgen`s Biologic Aimovig (Erenumab) Receives Approval in the U.S.
03 Oct 2022 //
FDA
Amgen`s Biologic Aimovig (Erenumab-Aooe) Receives Approval in the U.S.
15 Aug 2022 //
FDA
Novartis, Amgen settle their yearslong Aimovig dispute
02 Feb 2022 //
FIERCEPHARMA
Aimovig displays superiority over topiramate in migraine study
09 Nov 2021 //
EUROPEANPHARMACEUTICALREVIEW
AbbVie follows Biohaven into oral CGRP for migraine prevention
29 Sep 2021 //
FIERCEPHARMA
AbbVie`s oral migraine treatment atogepant nears FDA decision
20 Aug 2021 //
FIERCEBIOTECH
Amgen’s Aimovig gets Japanese marketing approval
23 Jun 2021 //
PHARMABIZ
Amgen Announces Approval Of Aimovig® (Erenumab) In Japan
23 Jun 2021 //
PRNEWSWIRE
Novartis hands U.S. operations for migraine drug to Amgen
16 Jun 2021 //
FIERCEPHARMA
Novartis’ migraine medicine trial meets endpoints
03 Nov 2020 //
CLINICALTRIALSARENA
Novartis announces positive results from a Phase IV study showing tolerability
02 Nov 2020 //
PRESS RELEASE
Aimovig reduces frequency of episodic migraines, five-year data reveals
06 Oct 2020 //
PHARMAFILE
Aimovig reduces frequency of episodic migraines, five-year data reveals
05 Oct 2020 //
PHARMAFILE
Amgen Files Erenumab for Migraine Prevention in Japan
17 Sep 2020 //
PHARMA JAPAN
Novartis finds employer support matters when treating migraines
16 Jun 2020 //
FIERCE PHARMA
Novartis, Amgen tout Aimovig`s benefits with real-world and long-term data
18 Apr 2020 //
FIERCEPHARMA
New data back long-term use of Novartis` Aimovig in migraine
17 Apr 2020 //
PHARMATIMES
New data back long-term use of Novartis` Aimovig in migraine
16 Apr 2020 //
PHARMATIMES
Novartis announces data in Neurology real-world & long-term safety of Aimovig®
15 Apr 2020 //
NOVARTIS
Amgen`s Aimovig (Erenumab aooe ) Receives Supplemental Approval In US
20 Feb 2020 //
FDA
NICE to request Aimovig evidence, appeal panel rules
05 Feb 2020 //
PHARMATIMES
Amgen exits neuroscience R&D to focus on growth areas
31 Oct 2019 //
PMLIVE
Amgen posts higher biosimilar sales, ends neuroscience program
29 Oct 2019 //
REUTERS
Amgen Inc.`s Aimovig (Erenumab-AOOE) Receives Supplemental Approval in US
08 Oct 2019 //
FDA
Amgen`s Aimovig, under fire from Lilly, loses grip on CGRP share
05 Sep 2019 //
FIERCE PHARMA
Aimovig shows long-term efficacy where other treatments fail
01 Jul 2019 //
PHARMATIMES
Lilly enlists patients to raise cluster headache awareness
26 Jun 2019 //
FIERCE PHARMA
Lilly`s scored its cluster headache nod for Emgality
05 Jun 2019 //
FIERCE PHARMA
Amgen To Highlight Extensive Long-Term Safety And Efficacy Data Of Aimovig®
02 May 2019 //
PR NEWS WIRE
Repatha, Aimovig flail as cheap copies eat into Amgen sales
01 May 2019 //
FIERCE PHARMA
The obscure advisory committees at the heart of the U.S. drug pricing debate
30 Apr 2019 //
REUTERS
Amgen`s Repatha (Evolocumab) Receives Approval in US
13 Mar 2019 //
FDA
Botox can hold its own in growing migraine field: Allergan exec`s
31 Jan 2019 //
FIERCE PHARMA
Can Botox hang with CGRP in migraine? Allergan says yes
15 Jan 2019 //
FIERCE PHARMA
NICE turns down Novartis` Aimovig, flagging clinical trial concerns
11 Jan 2019 //
BIOPHARMA DIVE
Novartis migraine drug not cost effective - UK price watchdog
11 Jan 2019 //
REUTERS
As pharmas revert to regular price hikes, Azar threatens action
10 Jan 2019 //
BIOPHARMA DIVE
Top 9 Really Cool Life Science Discoveries of the Year
10 Dec 2018 //
BIOSPACE
Amgen launches TV spot for Aimovig in tight CGRP market
17 Oct 2018 //
BIOPHARMA DIVE
Teva has buyer for plant in Israel that could save 200 jobs: report
10 Oct 2018 //
FIERCE PHARMA
Was last week`s Teva sell-off warranted? Depends who you ask
03 Oct 2018 //
FIERCE PHARMA
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
28 Sep 2018 //
XCONOMY
Three new drugs will compete fiercely to revolutionize migraine treatment
28 Sep 2018 //
MARKET WATCH
Teva wins much-needed US approval of migraine drug
14 Sep 2018 //
BIOPHARMA DIVE
Aimovig`s launch trends `bode well` for other CGRPs: analyst
21 Aug 2018 //
FIERCE PHARMA
Novartis` Aimovig(erenumab) Receives Approval in Europe
10 Aug 2018 //
EMA
Teva confident in September approval for migraine drug despite Celltrion 483
09 Aug 2018 //
FIERCE PHARMA
Breakthrough migraine prevention treatment approved in Europe
31 Jul 2018 //
PHARMAPHORUM
Novartis` migraine drug gets EMA approval
31 Jul 2018 //
PHARMA TIMES
First new migraine drug will be available in Britain as EMA grants licence
30 Jul 2018 //
DAILYMAIL UK
ICER to payers: Go easy on CGRP restrictions if pricing stays reasonable
05 Jul 2018 //
FIERCE PHARMA
Amgen `overwhelmed` by early interest in Aimovig: expert
03 Jul 2018 //
FIERCE PHARMA
Mylan biosim ready to challenge Amgen blockbuster Neulasta
06 Jun 2018 //
FIERCE PHARMA
Thanks to lower-than-expected price, ICER backs Amgen`s Aimovig
01 Jun 2018 //
FIERCE PHARMA
Amgen Snags FDA Approval for Migraine Drug With $6900 Annual List Price
18 May 2018 //
RAPS
